United States · Venture startup

Who invested in Angiocrine Bioscience

2 rounds we have observed, with the 0 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Follow Angiocrine Bioscience and see its new rounds in your feed.Start following

Funding summaryUpdated 31 Oct 2026

$6.1Mraised across 2 rounds since 2013, from 2 sources

$4.0MVenture$2.1MVenture

Latest round: Venture, $2.1MSept 2025
Biggest round: $4.0MVenture · Mar 2013
Investors: 0

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2013201520172019202120232025

$4.0MVenture$2.1MVenture

First round: Venture, $4.0M
Biggest round: $4.0M
Between rounds: 12.5 years

The rounds

Sept 2025
Venture$2.1M
No investor was named in the report.
Source recordedSEC filing: $2.1M sold, first sale Aug 2025
Mar 2013
Venture$4.0M
No investor was named in the report.
Reported by sec.govSEC filing: $4.0M sold, first sale Mar 2013

Also claim to have backed them

This firm lists Angiocrine Bioscience as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.